AI assistant
Sending…
Sarepta Therapeutics, Inc. — Director's Dealing 2021
Jun 3, 2021
31721_dirs_2021-06-03_afef923f-4d5d-4c83-92cf-fd10ec4e9eb6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Sarepta Therapeutics, Inc. (SRPT)
CIK: 0000873303
Period of Report: 2021-06-01
Reporting Person: Brown Ryan Edward (SVP, General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-01 | Common Stock | F | 64 | $76.01 | Disposed | 19368 | Direct |
Footnotes
F1: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on May 31, 2019.
More from Sarepta Therapeutics, Inc.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 6
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 4